In the future, perhaps any and all new indications for drugs will be discovered and brought forth before approval. Moving in this direction is a new project involving Pfizer and Caliper, which will perform in-vivo tests evaluating new indications for drugs in Pfizer's pipeline. For more, here is the press release.
In case you missed this, the Center for Public Integrity reported today that pharma spent $155 million on lobbying between January 2005 and June 2006. For more from its report, click here. PhRMA alone spent $18 million, but individually, Pfizer, GSK and Merck were said to be the biggest spenders.